| Pharmaceutical active ingredients: |
| Nitisinone |
| Available forms, composition and doses of Nitisone: |
| N / A |
| Nitisone medical category: |
| Human:4-Hydroxyphenylpyruvate oxidase inhibitorsHereditary tyrosinemia type 1 treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A16AX04 - Nitisinone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Niteban | Isoniazid | Unidentified Pharmaceutical Company |
| Niter | Potassium Nitrate | Unidentified Pharmaceutical Company |
| Niter Cake | Sulfuric Acid | Unidentified Pharmaceutical Company |
| Nitex | Isosorbide Mononitrate | Unidentified Pharmaceutical Company |
| Niticolin | Citicoline | Unidentified Pharmaceutical Company |
| Nitobanil | Tegafur | Unidentified Pharmaceutical Company |
| Nitoin | Nitrofurantoin | Unidentified Pharmaceutical Company |
| Nitora | Nitroglycerin | Unidentified Pharmaceutical Company |
| Nitran | Nitroglycerin | Unidentified Pharmaceutical Company |
| Nitre Cake | Sulfuric Acid | Unidentified Pharmaceutical Company |